Literature DB >> 11137512

Risk factors for hip fracture among elderly patients with Parkinson's disease.

Y Sato1, M Kaji, T Tsuru, K Oizumi.   

Abstract

Incidence of hip fracture among patients with Parkinson's disease (PD) is high, especially in elderly women. To determine effects of various factors on hip fracture risk, we prospectively studied fractures in a cohort of 115 elderly patients of both genders with PD (46 men, 69 women; mean age, 71.9 years) for 1 year. At baseline, we recorded body mass index (BMI), Hoehn and Yahr stage, and postmenopausal interval, and also measured bone mineral density (BMD) and serum concentrations of ionized calcium, intact parathyroid hormone (PTH), pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP; a bone resorption marker), and 25-hydroxyvitamin (25-OHD). During the year hip fractures occurred in 18 patients (2 male and 16 female). We compared baseline variables between patients with and without hip fracture. PD patients with decreased BMI, lower BMD, and low concentrations of serum ionized calcium, and 25-OHD (mean 4.0 ng/ml) with compensatory hyperparathyroidsim had increased risk of hip fracture. Female PD patients with long postmenopausal intervals also had increased hip fracture risk. BMI, illness duration, postmenopausal intervals, Hoehn and Yahr stage, 25-OHD, PTH, calcium, and ICTP were determinants of BMD in patients with fracture. Elderly PD patients with low BMI, low BMD, and serum 25-OHD concentrations < or =5 ng/ml with secondary hyperparathyroidism have increased risk of hip fracture, as do female PD patients with long postmenopausal intervals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137512     DOI: 10.1016/s0022-510x(00)00458-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  35 in total

1.  Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.

Authors:  Anne-Marie A Wills; Adriana Pérez; Jue Wang; Xiao Su; John Morgan; Suja S Rajan; Maureen A Leehey; Gregory M Pontone; Kelvin L Chou; Chizoba Umeh; Zoltan Mari; James Boyd
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302

Review 2.  How might physical activity benefit patients with Parkinson disease?

Authors:  Arlène D Speelman; Bart P van de Warrenburg; Marlies van Nimwegen; Giselle M Petzinger; Marten Munneke; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

3.  Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study.

Authors:  D R Williams; H C Watt; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

4.  Prevalence and risk factors of osteoporosis in patients with Parkinson's disease.

Authors:  A Bezza; Z Ouzzif; H Naji; L Achemlal; A Mounach; M Nouijai; A Bourazza; R Mossadeq; A El Maghraoui
Journal:  Rheumatol Int       Date:  2008-07-01       Impact factor: 2.631

5.  Risk of fracture in patients with Parkinson's disease.

Authors:  S Pouwels; M T Bazelier; A de Boer; W E J Weber; C Neef; C Cooper; F de Vries
Journal:  Osteoporos Int       Date:  2013-02-22       Impact factor: 4.507

Review 6.  Musculoskeletal problems in Parkinson's disease.

Authors:  Young Eun Kim; Beom S Jeon
Journal:  J Neural Transm (Vienna)       Date:  2013-02-19       Impact factor: 3.575

7.  Whole body vibration therapy in fracture prevention among adults with chronic disease.

Authors:  Marco Yc Pang
Journal:  World J Orthop       Date:  2010-11-18

8.  Comorbid Parkinson's disease, falls and fractures in the 2010 National Emergency Department Sample.

Authors:  Hind A Beydoun; May A Beydoun; Nishant K Mishra; Ola S Rostant; Alan B Zonderman; Shaker M Eid
Journal:  Parkinsonism Relat Disord       Date:  2016-11-19       Impact factor: 4.891

Review 9.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

Review 10.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.